Synapse News
McMaster and Kapoose Creek Bio set sights on new fungi-derived medicines in new $2.2M drug discovery partnership
Researchers at Kapoose Creek Bio partner with McMaster University to develop a new synthetic biology platform for fungi-derived medicines.
Synapse Life Science Consortium welcomes Launchit Ventures as its newest partner
The collaboration highlights a joint commitment to advancing the life sciences ecosystem across Hamilton and Ontario.
Made-in-Hamilton app speeds up lifesaving treatment for heart attacks
The Ontario Centre of Innovation recently announced $500,000 in provincial funding to expand a made-in-Hamilton smartphone app into the Ottawa region.
How femtech companies are tackling gender health gaps while empowering women
Growing a femtech company brings more challenges than successes, but these founders are focused on closing the women's healthcare gap.
McMaster and the University of Ottawa receive more than $115M to bolster pandemic preparedness in Canada
McMaster and University of Ottawa recieved funding from CBRF to expand Canada's biomanufacturing industry for development of technology and theraputics.
Success stories inspire the next generation of unicorn founders
Blockbuster AstraZeneca-Fusion Pharmaceuticals announcement shows Hamilton’s life science innovation ecosystem is thriving.
Over $170,000 awarded in cash and prizes through Innovation Factory’s eleventh annual Synapse Life Science Competition
D3RMIS Corp, Venamics Medical, Neuro Spinal Innovation and ParaSight Imaging Systems announced as 2024 Synapse Life Science Competition winners.
Fusion Pharmaceuticals to be acquired by AstraZeneca, accelerating development of next-generation radioconjugates to treat cancer
Hamilton-based Fusion Pharmaceuticals Inc. has entered into a definitive agreement to be acquired by AstraZeneca.
OBIO® Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards
11 women-led companies have been selected for the OBIO® WiHI Seed Program.